Long-Term Response to Vemurafenib Therapy in Patients with metastatic malignant Melanoma

被引：0
|
作者：
Groffik, A. [1 ]
Mueller-Brenne, T. [1 ]
Rudolph, B. [1 ]
Rietz, S. [1 ]
Grabbe, S. [1 ]
Loquai, C. [1 ]
机构：
[1] Univ Med Mainz, Hautklin, Mainz, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2013年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：908 / 908
页数：1
相关论文
共 50 条
  • [41] Systemic therapy for unresectable metastatic melanoma: Impact of biochemotherapy on long-term survival
    Bedikian, Agop Y.
    Johnson, Marcella M.
    Warneke, Carla L.
    McIntyre, Susan
    Papadopoulos, Nicholas
    Hwu, Wen-Jen
    Kim, Kevin
    Hwu, Patrick
    JOURNAL OF IMMUNOTOXICOLOGY, 2008, 5 (02) : 201 - 207
  • [42] Treatment with vemurafenib in patients with metastatic melanoma.
    Ocvirk, Janja
    Boc, Marko
    Mesti, Tanja
    Rebersek, Martina
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] Delayed oral toxicity from long-term vemurafenib therapy
    Lloyd-Lavery, A.
    Hodgson, T.
    Coupe, N.
    Bond, S.
    Shah, K.
    Espinosa, O.
    Payne, M. J.
    Middleton, M. R.
    Matin, R. N.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (05) : 1159 - 1160
  • [44] Development of primary malignant Melanoma under Therapy with Vemurafenib
    Eleftheriadis, V
    Boettjer, J.
    Stadler, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 156 - 156
  • [45] Long-Term Survival After Stereotactic and Hypofractionated Radiation Therapy in Patients With Metastatic Melanoma Brain Metastases
    Casey, D. L.
    Yamada, Y.
    Chan, T. A.
    Yang, T. J.
    Wolchok, J. D.
    Postow, M. A.
    Brennan, C. W.
    Tabar, V. S.
    Gutin, P. H.
    Beal, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E67 - E67
  • [46] A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma
    Deniger, Drew C.
    Kwong, Mei Li M.
    Pasetto, Anna
    Dudley, Mark E.
    Wunderlich, John R.
    Langhan, Michelle M.
    Lee, Chyi-Chia Richard
    Rosenberg, Steven A.
    CLINICAL CANCER RESEARCH, 2017, 23 (02) : 351 - 362
  • [47] Different Faces of Hepatotoxicity in Patients With Metastatic Melanoma on Combination Vemurafenib and Ipilimumab Therapy
    Simoes, Priya
    Wolchok, Jedd
    Chapman, Paul
    Gambarin-Gelwan, Maya
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S392 - S392
  • [48] Long-term survival with modern therapeutic agents against metastatic melanoma-vemurafenib and ipilimumab in a daily life setting
    Lang, B. M.
    Peveling-Oberhag, A.
    Faidt, D.
    Hoetker, A. M.
    Weyer-Elberich, V.
    Grabbe, S.
    Loquai, C.
    MEDICAL ONCOLOGY, 2018, 35 (03)
  • [49] Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study
    Queirolo, Paola
    Dozin, Beatrice
    Morabito, Anna
    Banelli, Barbara
    Piccioli, Patrizia
    Fava, Cristiana
    Leo, Claudio
    Carosio, Roberta
    Laurent, Stefania
    Fontana, Vincenzo
    Ferrucci, Pier Francesco
    Martinoli, Chiara
    Cocorocchio, Emilia
    Battaglia, Angelo
    Ascierto, Paolo A.
    Capone, Mariaelena
    Simeone, Ester
    De Galitiis, Federica
    Pagani, Elena
    Cappellini, Gian Carlo Antonini
    Marchetti, Paolo
    Guida, Michele
    Tommasi, Stefania
    Mandala, Mario
    Merelli, Barbara
    Quaglino, Pietro
    Fava, Paolo
    Guidoboni, Massimo
    Romani, Massimo
    Spagnolo, Francesco
    Pistillo, Maria Pia
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [50] LONG-TERM SURVIVAL AFTER REMOVAL OF METASTATIC MALIGNANT MELANOMA OF BRAIN - REPORT OF 2 CASES
    MCCANN, WP
    WEIR, BKA
    ELVIDGE, AR
    JOURNAL OF NEUROSURGERY, 1968, 28 (05) : 483 - &
12345